A new report examines why linked data is essential to advancing healthcare and improving outcomes for patients.

The European Medicines Agency’s CHMP has recommended approval of Gilead Sciences’ lenacapavir, a twice-yearly injection for preventing HIV infection.

The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of VRd for multiple myeloma.

The US biopharma has planted roots in the UK’s biotech cluster as it bets on synthetic rescue to unlock new treatments for rare diseases.

Hengrui Pharma has signed an agreement with GSK for the development of up to 12 innovative medicines across several therapeutic areas.

Sarepta said it accepts the CHMP decision on Elevidys, while partner Roche said it will continue working with the EMA.

In 2025, Turbine took the first steps in opening its powerful cell simulation platform to the wider drug development ...

A federal district court in Delaware ruled that Viatris’ product, currently awaiting approval from the US Food and Drug Administration (FDA), does not infringe on Novo Nordisk’s patent for the ...

Growing budgetary pressure is a central theme in France as it prepares for the publication of the government's 2026 Social Security Finance Bill (PLFSS).

The clinical trial industry has long recognized the importance of standardization in driving efficiency and ensuring data quality. Efforts ...

In today’s tech-driven landscape, it seems like every software solution in the clinical industry needs to have some AI ...

Sanofi has signed an agreement to acquire Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities.